BOSTON--(BUSINESS WIRE)--Pyxis Oncology, an immuno-oncology company focused on developing a new family of antibody-based immunotherapies derived from novel insights into the biology of the tumor ...
Pyxis Controls, specialist in Building Management and Home Automation, today announced the launch of NAViGO, a real breakthrough innovation in home entertainment. 11 November 2009 NAViGO - a never ...
On Wednesday, Pyxis Oncology, Inc. (NASDAQ:PYXS) released preliminary data from the ongoing Phase 1 clinical dose escalation study evaluating PYX-201 in multiple solid tumors. Among evaluable Head and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback